PediDose exploited advanced Monte Carlo simulations, anthropomorphic computational phantoms, and Artificial Intelligence techniques to develop a simulated dosimetry database. 

Benefits:

  1. Significant strengthening of value proposition for IKHs product Evorad® achieved.
  2. €1.25m additional total income expected through increased sales of Evorad®.
  3. Medical market entry for BIOEMTECH facilitated through partnership with IKH.

    Read all the details of the success story and watch the video here.
No Tag